Vitamin D3 and Reduced Serum Creatine Phosphokinase Level

Doses used in studies

IU single-dose: 300,000 (median 300,000, IQR 300,000–300,000) — 1 study

Time to effect

Median: 2 weeks · IQR 2 weeks–2 weeks · Range 2 weeks–2 weeks — Reported in 1 of 1 study

1 of 1 paper

The Effect of Vitamin D3 on Serum Creatine Phosphokinase Level in Patients with Multiple Trauma: A Pilot Randomized Clinical Trial.

2025-01-01
RCT
Iranian journal of medical sciences 50(1)
- Mehran Kouchek
- Niloufar Taherpour
- Mahya Farasat
- Mirmohammad Miri
- Sara Salarian
- Seyedpouzhia Shojaei
- Rezvan Hassanpour
- Hossein Amini
- Mohammad Sistanizad

PubMed: 39957812
DOI: 10.30476/ijms.2024.99691.3182

3 Insights on

Reduced Serum Creatine Phosphokinase Level

High evidence
Clinical

Unlike control groups, the significant steadily decreasing trend was seen only in the intervention group (P<0.001). This significant decrease in the intervention arm was observed on days 5 to 7 (P=0.001) and on days 8 to 10 (P<0.001) compared to the baseline.

Effect: Beneficial
Effect size: Moderate
Significant: Yes
Dose: 300,000 units